Evidence map›Paper›PMID 42249023›Full record

ArticlePediatric research2026

The protective effect of cutaneous vagus nerve stimulation from necrotizing enterocolitis (NEC) in neonatal rats.

Mark E Baker, Georgi D Mladenov, Andrei Radulescu, Andrew O Hopper, Brigette A Li, Christopher G Wilson

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mark E BakerDepartment of Pediatrics, Division of Neonatology, Intermountain Healthcare, St. Vincent Regional Hospital, Billings, MT, USA.
Georgi D MladenovDepartment of Surgery, Division of Pediatric Surgery, Loma Linda University Health, Loma Linda, CA, USA.
Andrei RadulescuDepartment of Surgery, Division of Pediatric Surgery, Loma Linda University Health, Loma Linda, CA, USA.
Andrew O HopperDepartment of Pediatrics, Division of Neonatology, Loma Linda University Health, Loma Linda, CA, USA.
Brigette A LiLoma Linda University School of Medicine, Loma Linda, CA, USA.
Christopher G WilsonDepartment of Pediatrics, Division of Neonatology, Loma Linda University Health, Loma Linda, CA, USA. cgwilson@llu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNecrotizing enterocolitis (NEC) is a major source of morbidity and mortality among premature infants. Vagus nerve stimulation (VNS) has proven anti-inflammatory effects. Animal studies indicate that vagus nerve activity may dampen NEC inflammation.

methodsWe used an animal model that induces NEC in rat pups. Newborn pups were divided into six treatment groups: Pups receiving NEC induction with Actual VNS, Sham VNS, and No VNS; and pups not receiving NEC induction with Actual VNS, Sham VNS, and No VNS (total n = 112). After death, gastrointestinal (GI) samples were graded 0-4 using the NEC Histologic Injury Scoring System. NEC incidence was defined as grades 2-4. Length of survival and premature mortality were also quantified.

resultsAmong NEC induction pups, the differences between NEC scores and NEC incidence were not statistically significant. However, those pups who received Actual VNS or Sham VNS had a longer average survival (p = 0.014) and lower chance of premature mortality (p = 0.004). These effects were stronger when Any VNS pups (Actual and Sham VNS pups combined) were compared to No VNS pups (p = 0.0009 and 0.003, respectively).

conclusionOur results suggest a possible protective effect of both electrical and tactile cutaneous VNS against mortality among NEC patients. IMPACT: Vagus nerve stimulation (VNS) has proven anti-inflammatory properties in human adults, and represents a possible new treatment for necrotizing enterocolitis (NEC). Using an animal model for NEC, we found that cutaneous VNS is protective against the development and severity of NEC. These protective effects held true for both electrical and tactile VNS. Our results suggest a potentially promising new treatment for NEC in the neonatal population.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.